Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
- Latest
- Trending
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Virchow, developed by Paige, detects rare cancers with 94% accuracy, transforming cancer diagnosis and patient outcomes.
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
Diamondback Energy and Endeavor Energy Resources are set to merge in a $26 billion deal, boosting Diamondback shares. Other companies ...
Discover the warning about tissue contamination when using AI in medicine. AI struggles to accurately analyze samples due to real-world ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.